MA27059A1 - Azithromycine en dose unique - Google Patents

Azithromycine en dose unique

Info

Publication number
MA27059A1
MA27059A1 MA27523A MA27523A MA27059A1 MA 27059 A1 MA27059 A1 MA 27059A1 MA 27523 A MA27523 A MA 27523A MA 27523 A MA27523 A MA 27523A MA 27059 A1 MA27059 A1 MA 27059A1
Authority
MA
Morocco
Prior art keywords
azithromycin
single dose
priorities
august
abstract
Prior art date
Application number
MA27523A
Other languages
English (en)
Inventor
Michael William Dunne
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA27059A1 publication Critical patent/MA27059A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

DEPOSANT Société dite: PFIZER PRODUCTS INC. REVENDICATION DE PRIORITES us 21 Août 2001 60/313,867 Voir en annexe le titre de l'invention et le texte de l'abrégé "Azithromycine en dose unique" La présente invention concerne une méthode de traitement d'infections respiratoires chez l'homme en administrant une dose unique d'azithromycine.
MA27523A 2001-08-21 2004-02-11 Azithromycine en dose unique MA27059A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31386701P 2001-08-21 2001-08-21

Publications (1)

Publication Number Publication Date
MA27059A1 true MA27059A1 (fr) 2004-12-20

Family

ID=23217490

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27523A MA27059A1 (fr) 2001-08-21 2004-02-11 Azithromycine en dose unique

Country Status (25)

Country Link
US (3) US20030148964A1 (fr)
EP (1) EP1418924A2 (fr)
JP (1) JP2005501862A (fr)
KR (1) KR20040032942A (fr)
AP (1) AP1729A (fr)
BG (1) BG108537A (fr)
BR (1) BR0211830A (fr)
CA (1) CA2458135A1 (fr)
CZ (1) CZ2004232A3 (fr)
EA (1) EA200400214A1 (fr)
EC (1) ECSP044985A (fr)
GE (1) GEP20063812B (fr)
HR (1) HRP20040163A2 (fr)
HU (1) HUP0401332A2 (fr)
IL (1) IL159585A0 (fr)
IS (1) IS7092A (fr)
MA (1) MA27059A1 (fr)
MX (1) MXPA04001605A (fr)
OA (1) OA12845A (fr)
PL (1) PL367888A1 (fr)
SK (1) SK1012004A3 (fr)
TN (1) TNSN04035A1 (fr)
WO (1) WO2003018031A2 (fr)
YU (1) YU8804A (fr)
ZA (1) ZA200400804B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1648473B1 (fr) * 2003-07-24 2009-01-28 PLIVA HRVATSKA d.o.o. Dose unique a dissolution rapide d'azithromycine
JP2007513139A (ja) 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
RU2331410C2 (ru) 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
CA2838111C (fr) 2005-12-08 2016-01-19 Insmed Incorporated Compositions a base de lipide d'anti-infectieux pour traiter des infections pulmonaires et procedes d'utilisation de celles-ci
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
WO2009114810A2 (fr) * 2008-03-14 2009-09-17 The Florida International Uinversity Board Of Trustees Utilisation d'ellagitannines comme inhibiteurs de la détection du quorum bactérien
WO2012170356A1 (fr) 2011-06-04 2012-12-13 Rochester General Hospital Research Institute Compositions et procédés associés à la protéine p6 de l'haemophilus influenzae
BR112015012351A8 (pt) 2012-11-29 2019-10-01 Insmed Inc composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo
WO2015175939A1 (fr) 2014-05-15 2015-11-19 Insmed Incorporated Méthodes de traitement d'infections pulmonaires mycobactériennes non-tuberculeuses
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法
EP4103725A4 (fr) * 2020-02-14 2024-03-27 Asklepios Biopharmaceutical Inc Procédé de traitement d'une toxicité associée à une thérapie génique avec des antibiotiques

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US53264A (en) * 1866-03-20 Improved ditching-machine
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (fr) 1987-09-10 1989-03-23 Pfizer Azithromycine et derives utilises comme agents anti-protozoaires
YU45590A (sh) 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
TW271400B (fr) 1992-07-30 1996-03-01 Pfizer
WO1994026758A1 (fr) 1993-05-19 1994-11-24 Pfizer Inc. Intermediaire s'appliquant a l'azithromycine
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
WO1995030422A1 (fr) 1994-05-06 1995-11-16 Pfizer Inc. Formes galeniques a liberation controlee de l'azithromycine
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US20040053264A1 (en) * 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips

Also Published As

Publication number Publication date
US20030148964A1 (en) 2003-08-07
PL367888A1 (en) 2005-03-07
BG108537A (bg) 2005-02-28
KR20040032942A (ko) 2004-04-17
US6987093B2 (en) 2006-01-17
TNSN04035A1 (fr) 2006-06-01
ZA200400804B (en) 2005-05-03
MXPA04001605A (es) 2004-07-08
EP1418924A2 (fr) 2004-05-19
HRP20040163A2 (en) 2005-02-28
US20040023898A1 (en) 2004-02-05
CZ2004232A3 (cs) 2005-10-12
BR0211830A (pt) 2004-09-08
WO2003018031A2 (fr) 2003-03-06
WO2003018031A3 (fr) 2003-10-02
AP2004002968A0 (en) 2004-03-31
HUP0401332A2 (hu) 2004-11-29
AP1729A (en) 2007-03-26
US7067493B2 (en) 2006-06-27
YU8804A (sh) 2006-08-17
CA2458135A1 (fr) 2003-03-06
US20050250712A1 (en) 2005-11-10
JP2005501862A (ja) 2005-01-20
EA200400214A1 (ru) 2004-06-24
IL159585A0 (en) 2004-06-01
SK1012004A3 (sk) 2005-04-01
IS7092A (is) 2003-12-23
GEP20063812B (en) 2006-05-10
ECSP044985A (es) 2004-04-28
OA12845A (en) 2006-09-15

Similar Documents

Publication Publication Date Title
MA27059A1 (fr) Azithromycine en dose unique
YU1097A (sh) 2-okso i 2-tio-1,2-dihidrohinolinil-oksazolidinoni
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
TW200510343A (en) Substituted dihydroquinazolines
AU2119200A (en) Medicament
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
GB0111186D0 (en) Novel compounds
MXPA03010549A (es) Formas de dosificacion de oxcarbazepina.
EP1037650A4 (fr) Procedes et compositions pour le traitement et la prevention d'infections a staphylococcus aureus
TW200510449A (en) Acylated nonadepsipeptides
BR0002577A (pt) Suspensões orais de trovafloxacina
TW200621799A (en) Acylated nonadepsipeptides II
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
EA200400436A1 (ru) Медикаменты для профилактики и лечения бромидроза
AU2003210850A8 (en) N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
BRPI0414139A (pt) métodos e composições para tratar infecções por herpes
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
WO2003024996A3 (fr) Macrocycles antibacteriens
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
DE50202865D1 (de) Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel